Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
3636 Mitsubishi Research Institute
- 4850
- 00.00%
20min DelayMarket Closed Dec 30 15:30 JST
77.81BMarket Cap15.33P/E (Static)
4900High4850Low23.10KVolume4850Open4850Pre Close112.47MTurnover537052wk High0.26%Turnover Ratio16.04MShares361552wk Low316.44EPS TTM42.72BFloat Cap5770Historical High15.33P/E (Static)8.81MShs Float1281Historical Low316.44EPS LYR1.03%Amplitude160.00Dividend TTM1.13P/B100Lot Size3.30%Div YieldTTM
Mitsubishi Research Institute Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.54%115.36B | -15.26%38.87B | 0.76%27.67B | 4.72%122.13B | 1.21%25.25B | 0.62%23.55B | 6.90%45.87B | 8.29%27.46B | 13.19%116.62B | 10.25%24.95B |
| Cost of revenue | -6.45%89.94B | -19.59%27.89B | 2.10%21.31B | 6.78%96.14B | 0.61%20.74B | 5.37%19.84B | 11.05%34.69B | 7.82%20.87B | 13.14%90.04B | 13.49%20.62B |
| Gross profit | -2.17%25.42B | -1.82%10.98B | -3.49%6.36B | -2.24%25.98B | 4.04%4.51B | -18.91%3.71B | -4.23%11.18B | 9.82%6.59B | 13.36%26.58B | -2.94%4.33B |
| Operating expense | 6.15%18.36B | 3.86%4.41B | 2.18%4.32B | -0.69%17.3B | -6.62%4.2B | 1.34%4.62B | 1.24%4.25B | 1.56%4.23B | 4.95%17.42B | 5.96%4.5B |
| Operating profit | -18.74%7.06B | -5.31%6.57B | -13.65%2.04B | -5.19%8.69B | 276.61%302M | -4,213.64%-905M | -7.30%6.93B | 28.56%2.36B | 33.72%9.17B | -180.28%-171M |
| Net non-operating interest income (expenses) | 85.71%-3M | 83.33%-1M | 85.71%-1M | 19.23%-21M | 62.50%-3M | 37.50%-5M | -50.00%-6M | -16.67%-7M | 21.21%-26M | -33.33%-8M |
| Non-operating interest income | 450.00%11M | --7M | --3M | -75.00%2M | --2M | --0 | --0 | --0 | 14.29%8M | --0 |
| Non-operating interest expense | -39.13%14M | 33.33%8M | -42.86%4M | -32.35%23M | -37.50%5M | -37.50%5M | -33.33%6M | -22.22%7M | -15.00%34M | -20.00%8M |
| Net investment income | 3.24%223M | -30.77%9M | 16.98%62M | 27.81%216M | 33.33%4M | 35.19%146M | 8.33%13M | 15.22%53M | 1.81%169M | -78.57%3M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 292.31%102M | -5M | -33M | -98.50%26M | -77.59%26M | 0 | 0 | 0 | 453.85%1.73B | 197.44%116M |
| Income from associates and other participating interests | -28.69%619M | -10.95%179M | 31.09%312M | -29.94%868M | -87.47%50M | 70.72%379M | -25.83%201M | -31.41%238M | 132.89%1.24B | 838.89%399M |
| Special income (charges) | 10.09%-285M | -350.00%-45M | 81.36%-11M | -138.35%-317M | -138.38%-236M | -33.33%-12M | 52.38%-10M | -1,375.00%-59M | -478.26%-133M | -661.54%-99M |
| Less:Other special charges | -5.06%75M | 325.00%17M | 83.33%11M | 61.22%79M | 280.00%57M | 33.33%12M | -80.95%4M | 50.00%6M | 113.04%49M | 15.38%15M |
| Less:Write off | -11.76%210M | 366.67%28M | --0 | 183.33%238M | 113.10%179M | --0 | --6M | --53M | --84M | --84M |
| Other non-operating income (expenses) | 64.60%265M | 835.29%159M | -11.43%31M | 794.44%161M | 146.59%41M | -8.11%68M | 54.55%17M | 66.67%35M | 0.00%18M | -2,833.33%-88M |
| Income before tax | -17.04%7.98B | -4.04%6.86B | -8.52%2.39B | -20.89%9.62B | 21.05%184M | -151.48%-330M | -7.36%7.15B | -28.30%2.62B | 55.38%12.16B | -20.42%152M |
| Income tax | -2.50%2.42B | -0.44%1.59B | -8.58%1.03B | -30.05%2.48B | -343.04%-384M | -69.08%141M | -5.79%1.6B | -8.94%1.13B | 59.39%3.55B | 110.67%158M |
| Net income | -22.09%5.56B | -5.08%5.27B | -8.41%1.36B | -17.11%7.14B | 9,566.67%568M | -355.43%-470M | -7.82%5.55B | -38.29%1.49B | 53.77%8.61B | -105.13%-6M |
| Net income continuous operations | -22.09%5.56B | -5.08%5.27B | -8.47%1.36B | -17.12%7.14B | 9,566.67%568M | -354.59%-471M | -7.80%5.55B | -38.27%1.49B | 53.79%8.61B | -105.17%-6M |
| Noncontrolling interests | -34.47%557M | -15.60%238M | -19.11%182M | -5.97%850M | 100.00%214M | -15.13%129M | 6.82%282M | -40.94%225M | 52.96%904M | -30.97%107M |
| Net income attributable to the company | -20.42%5B | -4.51%5.03B | -6.58%1.18B | -18.42%6.29B | 415.18%353M | -2,032.26%-599M | -8.50%5.27B | -37.76%1.26B | 53.86%7.71B | -202.70%-112M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -20.42%5B | -4.51%5.03B | -6.58%1.18B | -18.42%6.29B | 415.18%353M | -2,032.26%-599M | -8.50%5.27B | -37.76%1.26B | 53.86%7.71B | -202.70%-112M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.33%316.44 | -2.99%317.04 | -4.47%74.13 | -17.36%392.27 | 427.92%23.02 | -2,217.47%-35.15 | -7.95%326.8 | -37.92%77.6 | 53.81%474.67 | -219.09%-7.02 |
| Diluted earnings per share | -19.33%316.44 | -2.99%317.04 | -4.47%74.13 | -17.36%392.27 | 416.21%22.1978 | -2,373.66%-37.7428 | -7.95%326.8 | -37.92%77.6 | 53.81%474.67 | -207.59%-7.02 |
| Dividend per share | 6.67%160 | 6.67%80 | 0 | 7.14%150 | -6.25%75 | 0 | 25.00%75 | 0 | 27.27%140 | 45.45%80 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |